Cerebrospinal fluid biomarkers of white matter lesions – cross‐sectional results from the LADIS study
Michael Jonsson, Anders Wallin(Lund University), Lars Rosengren(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Elisabeth C.W. van Straaten(Amsterdam Neuroscience), Åke Edman, Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), K. Lind(Medical University of Graz), Leonardo Pantoni(University of Florence), Domenico Inzitari(University of Florence), S. Syversen(University of Gothenburg)
Cited by 111
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k